|Articles|March 20, 2020
snapIoT Launches Mobile Device Management Module
Advertisement
snapIoT Inc., a San Diego-based provider of snapClinical, an mClinical platform for patient-centric engagement solutions, announces its Mobile Device Management module. The Mobile Device Management module is for the management of all smart phones and devices that are used throughout digitally enabled clinical trials to help ensure security, quality, and compliance.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
